Additional file 1 of Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials

Figshare 2026 Open access

Read full text
Authors: Laure Gossec, Andra Rodica Balanescu, Maria Antonietta D’Agostino, Alexis Ogdie, Philipp Sewerin, Yu Deng, Linyu Shi, Yoshiyuki Sugimoto, Sheng Zhong, Yunzhao Xing, Ralph Lippe, Mitsumasa Kishimoto
DOI: 10.6084/m9.figshare.31005735
Cited by: 0

Abstract

Supplementary Material 1: Supplementary Material_Final

Fields of Study & Subjects

Multiple Sclerosis Research Studies Inflammatory Bowel Disease Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Figshare
Publication date
1 January 2026